Established and evolving medical therapies for claudication in patients with peripheral arterial disease

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Nature Clinical Practice Cardiovascular Medicine

• Publication date

  2006-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/ncpcardio0660PMID 17063165
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Ang

  2006cited by this paper
• Brief Communication: Ramipril Markedly Improves Walking Ability in Patients with Peripheral Arterial Disease

  2006cited by this paper
• The US experience with cilostazol in treating intermittent claudication.

  2005cited by this paper
• Lower extremity disease among persons aged > or =40 years with and without diabetes--United States, 1999-2002.

  2005cited by this paper
• Ginkgo biloba special extract EGb 761 in the treatment of peripheral arterial occlusive disease (PAOD)--a review based on randomized, controlled studies.

  2004cited by this paper
• Effects of simvastatin on walking performance and symptoms of intermittent claudication in hypercholesterolemic patients with peripheral vascular disease.

  2003cited by this paper
• Evaluation of walking capacity over time in 500 patients with intermittent claudication who underwent clinical treatment.

  2003cited by this paper
• Gene therapy progress and prospects: therapeutic angiogenesis for limb and myocardial ischemia

  2003cited by this paper
• Cholesterol Reduction With Atorvastatin Improves Walking Distance in Patients With Peripheral Arterial Disease

  2003cited by this paper
• Statin Use and Leg Functioning in Patients With and Without Lower-Extremity Peripheral Arterial Disease

  2003cited by this paper
• Claudication of Vascular Endothelial Growth Factor 121 in Patients With Disabling Intermittent Disease : A Phase II Randomized , Double-Blind , Controlled Study of Adenoviral Delivery Regional Angiogenesis With Vascular Endothelial Growth Factor in Peripheral Arterial

  2003cited by this paper
• Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial.

  2002cited by this paper
• Current medical therapies for patients with peripheral arterial disease: a critical review.

  2002cited by this paper
• Exercise training for claudication.

  2002cited by this paper
• The effects of exercise training on walking function and perception of health status in elderly patients with peripheral arterial occlusive disease

  2002cited by this paper
• Effects of long-term exercise rehabilitation on claudication distances in patients with peripheral arterial disease: a randomized controlled trial.

  2002cited by this paper
• Effect of Cilostazol on Treadmill Walking, Community‐Based Walking Ability, and Health‐Related Quality of Life in Patients with Intermittent Claudication Due to Peripheral Arterial Disease: Meta‐Analysis of Six Randomized Controlled Trials

  2002cited by this paper
• Propionyl-L-carnitine improves exercise performance and functional status in patients with claudication

  2001cited by this paper
• Peripheral Arterial Disease Detection, Awareness, and Treatment in Primary Care

  2001cited by this paper
• Peripheral arterial disease detection, awareness, and treatment in primary care.

  2001cited by this paper
• Propionyl-L-carnitine improves exercise performance and functional status in patients with claudication.

  2001cited by this paper
• Effects of exercise rehabilitation on cardiovascular risk factors in older patients with peripheral arterial occlusive disease.

  2000cited by this paper
• Exercise for intermittent claudication.

  2000cited by this paper
• Improved functional outcomes following exercise rehabilitation in patients with intermittent claudication.

  2000cited by this paper
• A comparison of cilostazol and pentoxifylline for treating intermittent claudication.

  2000cited by this paper
• Exercise training in intermittent claudication.

  2000cited by this paper
• Reliability of treadmill testing in peripheral arterial disease: a comparison of a constant load with a graded load treadmill protocol

  1999cited by this paper
• European multicenter study on propionyl-L-carnitine in intermittent claudication.

  1999cited by this paper
• Measurement of walking endurance and walking velocity with questionnaire: validation of the walking impairment questionnaire in men and women with peripheral arterial disease.

  1998cited by this paper
• Exercise therapy for intermittent claudication: a review of the quality of randomised clinical trials and evaluation of predictive factors.

  1998cited by this paper
• The Epidemiology of Peripheral Arterial Disease: Importance of Identifying the Population at Risk

  1997cited by this paper
• Exercise in the Treatment of Claudication: Assessment and Treatment of Functional Impairment

  1997cited by this paper
• Exercise training improves functional status in patients with peripheral arterial disease.

  1996cited by this paper
• The Correlation between Symptoms and Non-Invasive Test Results in Patients Referred for Peripheral Arterial Disease Testing

  1996cited by this paper
• Exercise Rehabilitation Programs for the Treatment of Claudication Pain: A Meta-analysis

  1995cited by this paper
• Effect of diagnostic criteria on the prevalence of peripheral arterial disease. The San Luis Valley Diabetes Study.

  1995cited by this paper
• Propionyl-L-carnitine in intermittent claudication: double-blind, placebo-controlled, dose titration, multicenter study.

  1995cited by this paper
• Exercise rehabilitation programs for the treatment of claudication pain. A meta-analysis.

  1995cited by this paper
• Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

  1994cited by this paper
• Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease.

  1994cited by this paper
• Functional Benefits of Peripheral Vascular Bypass Surgery for Patients with Intermittent Claudication

  1993cited by this paper
• Functional Benefits of Peripheral Vascular Bypass Surgery for Patients with Intermittent Claudication

  1993cited by this paper
• Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group.

  1991cited by this paper
• Benefit of exercise conditioning for patients with peripheral arterial disease.

  1990cited by this paper
• The Evaluation of Exercise Performance in Patients with Peripheral Vascular Disease

  1988cited by this paper
• Pentoxifylline efficacy in the treatment of intermittent claudication: multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients.

  1982cited by this paper
• Intermittent claudication: is a supervised exercise class worth while?

  1980cited by this paper
• Clinical measurement of systolic pressures in limbs with arterial occlusive disease.

  1969cited by this paper
• Exercise and Intermittent Claudication: Blood Flow in the Calf Muscle During Walking Studied by the Xenon‐133 Clearance Method

  1969cited by this paper
• Pathophysiology and Natural History the Prevalence of Peripheral Arterial Disease in a Defined Population

  year unknowncited by this paper

• A Study to Compare Effectiveness of Strength Trainingalong with Treamill Walkingon Pain Free Walking Distanceand Quality of Life in Peripheral Arterial Occlusive Disorders

  2026cites this paper
• Joint torques and powers are reduced during ambulation for both limbs in patients with unilateral claudication

  2018cites this paper
• Peripheral Artery Disease and Exercise in Patients with Diabetes

  2018cites this paper
• Recommandations

  2018cites this paper
• [Follow-up of patients with chronic obstructive arterial disease, some months after their rehabilitation: Assessment of a therapeutic education program].

  2018cites this paper
• Impact of Partial Weight-bearing Therapy on Walking Performance in Patients with Peripheral Arterial Disease -

  2016cites this paper
• The Effect of Resistance Training on Vascular Function in Older Adults

  2016cites this paper
• Triple versus dual antiplatelet therapy after percutaneous coronary intervention for coronary bifurcation lesions: results from the COBIS (COronary BIfurcation Stent) II Registry

  2015cites this paper
• A randomized comparison study assessing the impact of cilostazol on the heart rate and arrhythmias by 24-hour ambulatory holter electrocardiographic monitoring after drug-eluting stent implantation for coronary artery disease.

  2015cites this paper
• Effect of Cilostazol Following Endovascular Intervention for Peripheral Artery Disease

  2015cites this paper
• Cilostazol eliminates adverse smoking outcome in patients with drug-eluting stent implantation.

  2014cites this paper
• NMR-Based metabolomic studies of breast cancer

  2013cites this paper
• Evaluation and Treatment of the Patient with Peripheral Arterial Disease

  2013cites this paper
• Exercise Therapy for Claudication: Latest Advances

  2013cites this paper
• Exercise Therapy for Claudication: Latest

  2013cites this paper
• From the Midwestern Vascular Surgical Society Joint torques and powers are reduced during ambulation for both limbs in patients with unilateral claudication

  2013cites this paper
• Triple versus dual antiplatelet therapy for coronary heart disease patients undergoing percutaneous coronary intervention: A meta-analysis

  2013cites this paper
• Comparison of On-Treatment Platelet Reactivity Between Triple Antiplatelet Therapy With Cilostazol and Standard Dual Antiplatelet Therapy in Patients Undergoing Coronary Interventions

  2013cites this paper
• Community walking programs for treatment of peripheral artery disease.

  2013cites this paper
• French Society of Cardiology guidelines for cardiac rehabilitation in adults.

  2012cites this paper
• A Meta-Analysis of Randomized Controlled Trials Appraising the Efficacy and Safety of Cilostazol after Coronary Artery Stent Implantation

  2012cites this paper
• Pharmacological treatment of intermittent claudication does not have a significant effect on gait impairments during claudication pain.

  2012cites this paper
• Aging: Drugs to Eliminate Methylglyoxal, a Reactive Glucose Metabolite, and Advanced Glycation Endproducts

  2012cites this paper
• Therapies for Improving Walking Distance in Intermittent Claudicatio

  2011cites this paper
• Extracorporeal Shock Wave Therapy for Ischemic Cardiovascular Disorders

  2011cites this paper
• Low-density lipoprotein lowering does not improve calf muscle perfusion, energetics, or exercise performance in peripheral arterial disease.

  2011cites this paper
• Assessment of gait dynamics in rats submitted to limb ischemia.

  2011cites this paper
• (PVD; PAD; Arteriosclerosis Obliterans; Atherosclerosis; Peripheral Vascular Arterial Disease)

  2011cites this paper
• Multicenter randomized trial evaluating the efficacy of cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease: results of the CILON-T (influence of CILostazol-based triple antiplatelet therapy ON ischemic complication after drug-eluting stenT

  2011cites this paper
• Multicenter Randomized Trial Evaluating the Efficacy of Cilostazol on Ischemic Vascular Complications After Drug-Eluting Stent Implantation for Coronary Heart Disease

  2011cites this paper
• Comparative evaluation of pentoxyphylline and sulodexide effectiveness in the treatment of symptomatic arteriosclerosis obliterans

  2010cites this paper
• Initial Results of a 12-week, Institution-based, Supervised Exercise Rehabilitation Program for the Management of Peripheral Arterial Disease

  2010cites this paper
• Current management of intermittent claudication: the role of pharmacological and nonpharmacological symptom-directed therapies.

  2009cites this paper
• Extracorporeal shock wave therapy as a new and non-invasive angiogenic strategy.

  2009cites this paper
• Influence of the Duffy Antigen on Pharmacokinetics and Pharmacodynamics of Recombinant Monocyte Chemoattractant Protein (MCP-1, CCL-2) in Vivo

  2009cites this paper
• Does diabetes mellitus play a role in restenosis and patency rates following lower extremity peripheral arterial revascularization? A critical overview.

  2008cites this paper
• ¿Qué papel desempeña la diabetes mellitus en las tasas de reestenosis y permeabilidad tras la revascularización infrainginal? Revisión crítica

  2008cites this paper
• One-Year Prospective Health-Related Quality-Of-Life Outcomes in Patients Treated with Conservative Method, Endovascular Treatment or Open Surgery for Symptomatic Lower Limb Atherosclerotic Disease

  2008cites this paper
• Le diabète joue-t-il un rôle dans les resténoses et les taux de perméabilité après revascularisation artérielle des membres inferieurs ? une étude générale critique

  2008cites this paper
• The role of exercise training in peripheral arterial disease

  2007cites this paper